
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients
Author(s) -
Cecelia Miller,
Ying Huang,
Amy S. Ruppert,
Jadwiga Labanowska,
Samantha Jaglowski,
Kami J. Maddocks,
Kerry A. Rogers,
Seema A. Bhat,
Adam S Kittai,
Michael R. Grever,
Rosa Lapalombella,
Lynne V. Abruzzo,
Nyla A. Heerema,
John C. Byrd,
Erin Hertlein,
Jennifer A. Woyach
Publication year - 2021
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01237-x
Subject(s) - ibrutinib , chronic lymphocytic leukemia , leukemia , medicine , oncology , philadelphia chromosome , cancer research , biology , genetics , chromosomal translocation , gene